TraQ-header
TraQ Program of the PBCO

< Back to Case A3

 Panel  results - eluate (Twin A) 
 

Patient name: Twin A        

Cell Rh Rhesus Kell Duffy Kidd MNSs P Lewis Lu Results   Cell
    C D E c e Cw K k Kpa Fya Fyb Jka Jkb M N S s P1 Lea Leb Lua Lub
IAT*
 
1 R1wR1 + + 0 0 + + 0 + 0 + + 0 0 + + 0 + +S + 0 0 + 0 1
2 R1R1 + + 0 0 + 0 0 + 0 0 + + 0 + 0 + 0 + 0 + + 0 2+ 2
3 R1R1 + + 0 0 + 0 + 0 0 0 + + 0 + 0 + 0 + 0 + 0 +   3
4 R1R1 + + 0 0 + 0 0 + 0 0 + + + + 0 + 0 +S 0 + 0 +   4
5 R2R2 0 + + + 0 0 0 + 0 + 0 + 0 + 0 0 + + + 0 0 +   5
6 R2R2 0 + + + 0 0 + 0 0 + + + + + 0 + 0 + 0 + 0 +   6
7 R2R2 0 + + + 0 0 0 + 0 + + 0 + + 0 + 0 + 0 + 0 + 2+ 7
8 R2R2 0 + + + 0 0 0 + 0 + + 0 + + 0 + 0 + 0 + 0 + 2+ 8
9 rr 0 0 0 + + 0 + + 0 0 + 0 + 0 + + + +S + 0 0 + w+ 9
10 rr 0 0 0 + + 0 0 + 0 0 + 0 + 0 + + + + + 0 0 + w+ 10
11 Auto     11

*IAT done using eluate prepared from infant's DAT-positive red cells
IgG sensitized cells added to negative IATs worked

Self Test

Which maternal antibodies appear to be causing hemolytic disease of the newborn (HDN) in Twin A? Are the antibodies in the eluate consistent with the newborn's antigen typing results?

answer

 

< Back to Case A3

 

Copyright © 2002 - 2010, TraQ Program of the British Columbia Provincial Blood Coordinating Office, a program of the Provincial Health Services Authority. All rights reserved.